TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26189844

Group type: EXPERIMENTAL
Intervention: Venturi mask
Number of subjects: 65

Group type: COMPARATOR
Intervention: Oxygen mask
Number of subjects: 65
Study: 24268503

Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 0
Study: 22404145

Group type: EXPERIMENTAL
Intervention: Carvedilol (50 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 21063110

Group type: EXPERIMENTAL
Intervention: Syzygium cumini aqueous leaves extract (ASc) at 100 μg/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Syzygium cumini aqueous leaves extract (ASc) at 200 μg/mL
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17409123

Group type: EXPERIMENTAL
Intervention: Bed Rest plus Hypercortisolemia (BRHC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bed Rest (BR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bed Rest plus Essential Amino Acid and Carbohydrate Supplement (BRAA)
Number of subjects: 0
Study: 15887586

Group type: EXPERIMENTAL
Intervention: Electrocautery
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Monopolar RFE
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bipolar RFE
Number of subjects: 50
Study: 11820060

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (asa)
Number of subjects: 0
Study: 9533996

Group type: EXPERIMENTAL
Intervention: Right ear (RE) advantage for lexical decision task
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tone discrimination task
Number of subjects: 26
Study: 7866479

Group type: EXPERIMENTAL
Intervention: Ultrasonic measurements of intra-abdominal depth
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ultrasonic measurements of intra-abdominal muscle-vertebra distance
Number of subjects: 46
Study: 2570286

Group type: EXPERIMENTAL
Intervention: UK 69 578 (a competitive inhibitor of endopeptidase 24.11)
Number of subjects: 0
Study: 326494

Group type: EXPERIMENTAL
Intervention: Nystatin cream
Number of subjects: 31

Group type: COMPARATOR
Intervention: Nystatin/triamcinolone acetonide combination cream
Number of subjects: 31
Study: 31362145

Group type: EXPERIMENTAL
Intervention: Worry Outcome Journal (WOJ)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Thought Log (TL)
Number of subjects: 51
Study: 28985238

Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT) after DOMS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maximum Isometric Voluntary Force (MIVF)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT) after 72 hours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mechanical Detection Threshold (MDT) and Mechanical Pain Threshold (MPT)
Number of subjects: 20
Study: 26044879

Group type: EXPERIMENTAL
Intervention: Ultra-brief intervention (UBI) delivered in three GP appointments over five weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Practice as usual (control group).
Number of subjects: 0
Study: 23474890

Group type: EXPERIMENTAL
Intervention: Codeine/Paracetamol 20/400 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Codeine/Paracetamol 40/800 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Codeine/Paracetamol 60/1200 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 21465774

Group type: EXPERIMENTAL
Intervention: Magnetolaserotherapy and n‐3 polyunsaturated fatty acids
Number of subjects: 0
Study: 19128957

Group type: EXPERIMENTAL
Intervention: Negative sentinel node biopsy without axillary dissection
Number of subjects: 3548

Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 3548
Study: 17559697

Group type: EXPERIMENTAL
Intervention: PS-OO
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: PS-SO
Number of subjects: 21

Group type: COMPARATOR
Intervention: OO
Number of subjects: 21
Study: 15067655

Group type: EXPERIMENTAL
Intervention: Bupivacaine 20 mL 0.5% (100 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (20 mL normal saline)
Number of subjects: 60
Study: 11535549

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 9647497

Group type: EXPERIMENTAL
Intervention: Soya-based vegetarian low-protein diet (VPD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Animal-based low-protein diet (APD)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 15
Study: 8291821

Group type: EXPERIMENTAL
Intervention: Three-session, nurse-delivered behavior modification program using a videotape and face-to-face counseling
Number of subjects: 93

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 93
Study: 3290233

Group type: EXPERIMENTAL
Intervention: Antimicrobial agent
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 31948604

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) gel therapy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Classic wound dressing (Control)
Number of subjects: 110
Study: 28503722

Group type: EXPERIMENTAL
Intervention: Ovarian stimulation (OS)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (no ovarian stimulation)
Number of subjects: 82
Study: 26612286

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine with midazolam (DM)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sufentanil with midazolam (SM)
Number of subjects: 50
Study: 23574758

Group type: EXPERIMENTAL
Intervention: Patient Assessment of Chronic Illness Care (PACIC) instrument
Number of subjects: 945
Study: 21440263

Group type: EXPERIMENTAL
Intervention: Microbial sealant (Kimberly‐Clark InteguSeal) applied to one leg
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional preparation of the other leg
Number of subjects: 47
Study: 20038402

Group type: EXPERIMENTAL
Intervention: Peri-interventional antibiotic treatment with cefuroxime, 20 mg/kg three times per day for 24 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prolonged antibiotic treatment with cefuroxime, 20 mg/kg three times per day for 7 days
Number of subjects: 40
Study: 16550663

Group type: EXPERIMENTAL
Intervention: Two hours of warming immediately after surgery
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Warmed groups (two hours and seven days of warming)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No warming (control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Seven days of warming
Number of subjects: 45
Study: 15329902

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin at 50 mg/m2 every 4 weeks for 6 cycles (Group B)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Pegylated liposomal doxorubicin at 25 mg/m2 every 2 weeks for 12 cycles (Group A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group B (50 mg/m2 every 4 weeks for 6 cycles)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group A (25 mg/m2 every 2 weeks for 12 cycles)
Number of subjects: 48
Study: 11061509

Group type: EXPERIMENTAL
Intervention: Arginine (ARG; 0.5 g/kg, iv, from 0-30 min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Recombinant human IGF-I (rhIGF-I; 20 microg/kg, sc, at -180 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GHRH plus ARG
Number of subjects: 6
Study: 9570358

Group type: EXPERIMENTAL
Intervention: Thyroid carcinoma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hepatocellular carcinoma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transitional cell carcinoma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gastric adenocarcinoma
Number of subjects: 0
Study: 8117630

Group type: EXPERIMENTAL
Intervention: Thoracic epidural morphine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Lumbar epidural morphine
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups (Thoracic and Lumbar)
Number of subjects: 27
Study: 2868337

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (SK) in addition to usual treatment
Number of subjects: 11712

Group type: COMPARATOR
Intervention: Control group (usual treatment only)
Number of subjects: 11712

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (SK)
Number of subjects: 11712
Study: 29681640

Group type: EXPERIMENTAL
Intervention: Optical low‐coherence reflectometry (OLCR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ultrasonic pachymetry (US)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of OLCR and US
Number of subjects: 30
Study: 27492105

Group type: EXPERIMENTAL
Intervention: Corneal collagen crosslinking (CXL)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (contralateral untreated eyes)
Number of subjects: 36
Study: 24999127

Group type: EXPERIMENTAL
Intervention: Percutaneous dilatational tracheostomy (PDT) using blue rhino technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Surgical tracheostomy (ST) using Charles G Durbin technique
Number of subjects: 80
Study: 22874424

Group type: EXPERIMENTAL
Intervention: High-carbohydrate beverage (3.4 g glucose + 3.1 g fructose per deciliter)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control beverage (0.0 g glucose + 0.0 g fructose per deciliter)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Low-carbohydrate beverage (1.7 g glucose + 1.6 g fructose per deciliter)
Number of subjects: 7
Study: 20336817

Group type: EXPERIMENTAL
Intervention: Informational internet web pages (addresses of three relevant anaesthesia and health-related websites)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no access to informational web pages)
Number of subjects: 0
Study: 18249327

Group type: EXPERIMENTAL
Intervention: Fenoldopam
Number of subjects: 1059
Study: 15879435

Group type: EXPERIMENTAL
Intervention: Budesonide (inhaled corticosteroid)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Albuterol (beta-agonist) with glucocorticoid
Number of subjects: 436

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436
Study: 14673758

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF) 250 microg administered subcutaneously 3 times/week for 16 weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Number of subjects: 116
Study: 10410058

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Music appreciation sessions (Control)
Number of subjects: 20
Study: 8883267

Group type: EXPERIMENTAL
Intervention: Intravenous heparin (5000 U bolus followed by 1000 U/h infusion)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Subcutaneous heparin (12,500 U every 12 h, started 4 h after streptokinase)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Patients with activated partial thromboplastin time greater than two times the control
Number of subjects: 28
Study: 1517726

Group type: EXPERIMENTAL
Intervention: Patient education intervention (10-15 minute discussion and handout)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Control group (no special intervention)
Number of subjects: 238
Study: 6091079

Group type: EXPERIMENTAL
Intervention: Antacid preparations
Number of subjects: 0
Study: 29786954

Group type: COMPARATOR
Intervention: Urinary metabolites analysis using NMR spectroscopy at day 10
Number of subjects: 75

Group type: COMPARATOR
Intervention: Urine lactate and pyroglutamate levels
Number of subjects: 75

Group type: COMPARATOR
Intervention: Logistic regression analysis of metabolite ratios
Number of subjects: 75

Group type: COMPARATOR
Intervention: Metabolite ratios (lactate/fumarate and BCAAs/pyroglutamate)
Number of subjects: 75
Study: 30183260

Group type: EXPERIMENTAL
Intervention: Hydrogel formulation of dapivirine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Film-based formulation of dapivirine
Number of subjects: 0
Study: 27111184

Group type: EXPERIMENTAL
Intervention: HIV/sexually transmitted infection (STI) risk‐reduction intervention
Number of subjects: 786
Study: 25205868

Group type: EXPERIMENTAL
Intervention: CNTF (Ciliary neurotrophic factor) delivered via intraocular microcapsules (20 ng/d)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: CNTF (Ciliary neurotrophic factor)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (untreated fellow eyes)
Number of subjects: 5
Study: 22842237

Group type: EXPERIMENTAL
Intervention: 4-week preconditioning programme (PRECON) with walking and hopping exercises (N=211)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Control group (N=221)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Comparison between PRECON and Control
Number of subjects: 432
Study: 20416132

Group type: EXPERIMENTAL
Intervention: Quercetin 150 mg per day for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18092452

Group type: EXPERIMENTAL
Intervention: LANAP treatment with Nd:YAG laser
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control treatment (scaling and root planing without laser)
Number of subjects: 12
Study: 16178945

Group type: EXPERIMENTAL
Intervention: Valdecoxib 40 mg
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Valdecoxib 20 mg
Number of subjects: 570

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 570
Study: 12632439

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (triamcinolone hexacetonide 40 mg) + supervised physiotherapy
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection alone
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Saline injection + supervised physiotherapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Saline injection alone (placebo group)
Number of subjects: 93
Study: 10503056

Group type: EXPERIMENTAL
Intervention: Auditory icons (car horn and skidding tyres)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional warnings (simple tone and voice saying 'ahead')
Number of subjects: 0
Study: 8719534

Group type: EXPERIMENTAL
Intervention: Local anesthetic cream (EMLA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control cream
Number of subjects: 16
Study: 1827575

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 1,200 mg/day (Group A: 28 patients)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CPA) 100 mg/day in combination with MPA (Group B: 20 patients)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 1,200 mg/day (Group A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CPA) 100 mg/day in combination with MPA (Group B)
Number of subjects: 48
Study: 7387963

Group type: EXPERIMENTAL
Intervention: Xenon arc photocoagulation treatment
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (untreated eyes)
Number of subjects: 99
Study: 30595080

Group type: EXPERIMENTAL
Intervention: Plasma NGAL (neutrophil gelatinase‐associated lipocalin)
Number of subjects: 1131
Study: 28096223

Group type: EXPERIMENTAL
Intervention: Combination therapy with pioglitazone plus weekly exenatide
Number of subjects: 231

Group type: COMPARATOR
Intervention: Basal plus prandial insulin therapy
Number of subjects: 231
Study: 27352329

Group type: EXPERIMENTAL
Intervention: Complete video-assisted thoracoscopic surgery (c-VATS) lobectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional lobectomy via thoracotomy
Number of subjects: 100
Study: 23781953

Group type: EXPERIMENTAL
Intervention: NLC group (2-mm needle-shape instruments)
Number of subjects: 60

Group type: COMPARATOR
Intervention: SILC group (single-incision laparoscopic cholecystectomy)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NLC group
Number of subjects: 60

Group type: COMPARATOR
Intervention: SILC group
Number of subjects: 60
Study: 21991732

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Meperidine (1 mg/kg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg) + Bupivacaine (5 mg/ml)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Meperidine (1 mg/kg) + Bupivacaine (5 mg/ml)
Number of subjects: 100
Study: 19438906

Group type: EXPERIMENTAL
Intervention: Pegvisomant monotherapy (PM) - 10 mg once daily initially, adjusted in 5-mg increments every 8 weeks based on IGF‐I levels
Number of subjects: 27

Group type: COMPARATOR
Intervention: Combination therapy of pegvisomant and long-acting octreotide (P-LAR) - LAR dosing remained fixed
Number of subjects: 27
Study: 17276147

Group type: EXPERIMENTAL
Intervention: Once daily (OD) tobramycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three times daily (TD) tobramycin
Number of subjects: 0
Study: 14665792

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 129

Group type: COMPARATOR
Intervention: Relaxation tape recordings
Number of subjects: 129
Study: 12742501

Group type: EXPERIMENTAL
Intervention: Rapamycin-eluting coronary artery stents
Number of subjects: 0
Study: 9476845

Group type: EXPERIMENTAL
Intervention: Group A (QEA, PSB, BAL)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Group B (QEA only)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 51

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 51
Study: 8751024

Group type: EXPERIMENTAL
Intervention: Jet-injection of recombinant human growth hormone (rhGH)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Needle-injection of recombinant human growth hormone (rhGH)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both treatments (jet-injection and needle-injection)
Number of subjects: 12
Study: 2208022

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Lower doses of chemotherapy
Number of subjects: 256
Study: 758386

Group type: EXPERIMENTAL
Intervention: Chest physiotherapy at extubation
Number of subjects: 65

Group type: COMPARATOR
Intervention: No physiotherapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Pre-physio period
Number of subjects: 65
Study: 31654397

Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide (N2O)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 28272716

Group type: EXPERIMENTAL
Intervention: NBCA medical adhesive for patch fixation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Without patch fixation (control group)
Number of subjects: 160
Study: 25950140

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (INT)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 118
Study: 24255071

Group type: EXPERIMENTAL
Intervention: Tasquinimod
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 21353720

Group type: EXPERIMENTAL
Intervention: G-CSF administered concurrently with radiotherapy (RT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Radiotherapy (66 Gy in 33 fractions or 45 Gy in 30 fractions) with cisplatin and etoposide
Number of subjects: 38
Study: 19210693

Group type: EXPERIMENTAL
Intervention: darunavir/RTV 800/100 mg qd
Number of subjects: 49

Group type: COMPARATOR
Intervention: atazanavir/RTV 300/100 mg qd
Number of subjects: 49
Study: 17944734

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) with stepwise reduction of CNI
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (maintenance CNI dose)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 75
Study: 15083442

Group type: EXPERIMENTAL
Intervention: Intervention group (behavioral techniques, social support, education to promote exercise)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 11422884

Group type: EXPERIMENTAL
Intervention: Melatonin 1 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Melatonin 6 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Triazolam 0.125 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Melatonin (all doses)
Number of subjects: 7
Study: 9548039

Group type: EXPERIMENTAL
Intervention: Sedation with intravenous midazolam (5 mg for those under 65 years or 3 mg for those aged 65 or more)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No sedation
Number of subjects: 100
Study: 29948282

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (Ca[OH]2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) gel
Number of subjects: 60
Study: 28578682

Group type: EXPERIMENTAL
Intervention: Group debriefings (n=26)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Leisure sessions (film viewings) (n=27)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Leisure sessions (n=27)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Regression analysis (n=48)
Number of subjects: 53
Study: 26163681

Group type: EXPERIMENTAL
Intervention: Loaded high-velocity training (LOAD, n = 30)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Unloaded high-velocity training (UNLOAD, n = 27)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both groups (LOAD and UNLOAD)
Number of subjects: 57
Study: 22113220

Group type: COMPARATOR
Intervention: Conventional treatment (Group A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Navigated treatment (Group B)
Number of subjects: 24
Study: 19772268

Group type: EXPERIMENTAL
Intervention: Early laser photocoagulation treatment
Number of subjects: 15
Study: 17324772

Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine (IPB)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 133
Study: 15196527

Group type: EXPERIMENTAL
Intervention: Ambulatory gait analysis system (Physilog)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Reference motion analyzer and force plate
Number of subjects: 28
Study: 12174103

Group type: EXPERIMENTAL
Intervention: Cipamfylline (0.15%) cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 17-butyrate (0.1%) cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 9798075

Group type: EXPERIMENTAL
Intervention: Clozapine treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Haloperidol treatment
Number of subjects: 17
Study: 7648380

Group type: EXPERIMENTAL
Intervention: Uni-Dur 800 mg once-daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Uni-Dur 400 mg twice-daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Uniphyl 800 mg once-daily
Number of subjects: 24